Conflict/competing interest: No stated conflict of interest.
Intravitreal injections: a review of the evidence for best practice
Article first published online: 25 JUN 2013
© 2012 The Authors. Clinical and Experimental Ophthalmology © 2012 Royal Australian and New Zealand College of Ophthalmologists
Clinical & Experimental Ophthalmology
Volume 41, Issue 5, pages 500–507, July 2013
How to Cite
Fagan, X. J. and Al-Qureshi, S. (2013), Intravitreal injections: a review of the evidence for best practice. Clinical & Experimental Ophthalmology, 41: 500–507. doi: 10.1111/ceo.12026
Funding sources: Dr Xavier J Fagan is currently employed as the Novartis Retinal Fellow at the Royal Victorian Eye and Ear Hospital.
- Issue published online: 25 JUN 2013
- Article first published online: 25 JUN 2013
- Accepted manuscript online: 19 OCT 2012 06:30AM EST
- Manuscript Received: 19 SEP 2012
- Manuscript Accepted: 19 SEP 2012
- intravitreal injection;
Intravitreal injection is a common procedure performed by ophthalmologists. It is a quick and targeted treatment for a number of ophthalmic conditions. Despite this, the potential to cause serious complications and patient discomfort cannot be ignored. This article presents the level of evidence in the scientific literature supporting common practices such as location of the procedure, anaesthetic choice, sterile procedure techniques, comparison of some common pharmaceutical agents and the use of antibiotics.